January 2020
Co-Manager (Follow-On)
Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
Exclusive Financial Advisor (Buy side)
